SCHEMBL5586791

SCHEMBL5586791

CCCOc1c(O)c(C(=O)O)c(F)c(F)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.41
KMT2A Q03164 3/20 0.34
PKM P14618 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
RECQL P46063 1/20 0.33
TSHR P16473 2/20 0.32
TP53 P04637 1/20 0.32
MEN1 O00255 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP1A2 P05177 1/20 0.32
GSTA1 P08263 2/20 0.32
GSTP1 P09211 2/20 0.32
GFER P55789 1/20 0.31
SLC5A1 P13866 1/20 0.31
SLC5A2 P31639 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5590011 0.90 ESR1 (0.50) ESR1TSHRTP53
SCHEMBL5588827 0.89 ESR1 (0.45) ESR1KMT2ATDP1TSHRTP53
SCHEMBL5588560 0.88 PLA2G2A (0.44) ESR1KMT2ATDP1TSHRTP53
SCHEMBL5590200 0.88 PLA2G2A (0.44) ESR1KMT2ATDP1TSHRTP53
SCHEMBL5590470 0.88 PLA2G2A (0.44) ESR1KMT2ATDP1TSHRTP53
SCHEMBL5587125 0.88 PLA2G2A (0.44) ESR1KMT2ATDP1TSHRTP53
SCHEMBL5590250 0.88 PLA2G2A (0.44) ESR1KMT2ATDP1TSHRTP53
SCHEMBL5587536 0.86 ESR1 (0.37) ESR1KMT2APKMSMN1; SMN2L3MBTL1
SCHEMBL9861359 0.84 ESR1 (0.38) ESR1KMT2APKMSMN1; SMN2L3MBTL1
SCHEMBL5588784 0.79 KMT2A (0.38) KMT2ASMN1; SMN2L3MBTL1TP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ESR1 1108/4885KMT2A 1733/4885PKM 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.